Additionally, Koch and colleagues have shown that only in APOE ε4 AD patients there is a strong association between cognitive decline, impaired cortical plasticity and CSF t-tau values, suggesting a relative susceptibility to APOE ε4 patients to the amount of tau-related pathological burden (Koch et al., 2017). The gene discussed is MAPT; the disease is Alzheimer disease.